Prescription label sheet

Description

FIG. 1 is a perspective view of a prescription label sheet of our new design; and,

FIG. 2 is a top plan view of the prescription label sheet of FIG. 1.

The broken lines in the drawings show a perimeter of the prescription label sheet and are included for the purpose of illustrating portions of the article that form no part of the claimed design.

Claims

CLAIM The ornamental design for a prescription label sheet, as shown and described.

---

Inventors:	Miceli; David A. (Reno, NV), Miceli; Joseph A. (Spencer, TN)
Applicant:	Name City State Country Type Tri State Distribution, Inc. Sparta TN US
Assignee:	Tri State Distribution, Inc. (Sparta, TN)
Appl. No.:	D/541,986
Filed:	October 9, 2015

---

Related U.S. Patent Documents

---

	Application Number	Filing Date	Patent Number	Issue Date
	13875785	May 2, 2013
	13804930	Mar 14, 2013
	13347288	Jan 10, 2012
	14304204	Jun 13, 2014
	13746671	Jan 22, 2013
	13347288	Jan 10, 2012
	14304103	Jun 13, 2014

---

Current U.S. Class:	D20/22
Current International Class:	1908
Field of Search:	;D20/11,22-29,40,99 ;D19/1,10

---

References Cited [Referenced By]

---

U.S. Patent Documents

487540	December 1892	Ralph
5096226	March 1992	Steffen
D350988	September 1994	Kravitz
6036231	March 2000	Foote et al.
D428930	August 2000	Dunlap
D431841	October 2000	Dunlap
6550171	April 2003	De Werra et al.
D500342	December 2004	Stewart et al.
D500524	January 2005	Stewart et al.
D503197	March 2005	Stewart et al.
D588200	March 2009	Langan et al.
D593613	June 2009	Langan et al.
D595361	June 2009	Langan et al.
D597608	August 2009	Langan et al.
D602534	October 2009	Langan et al.
D605228	December 2009	Langan et al.
D605229	December 2009	Langan et al.
D605230	December 2009	Langan et al.
D607941	January 2010	Langan et al.
D614703	April 2010	Langan et al.
D621879	August 2010	Langan et al.
D621880	August 2010	Langan et al.
D624595	September 2010	Langan et al.
D624596	September 2010	Langan et al.
D631910	February 2011	Irwin, Jr.
D633151	February 2011	Langan et al.
D634367	March 2011	Langan et al.
D634368	March 2011	Langan et al.
D634369	March 2011	Langan et al.
7918830	April 2011	Langan et al.
7942451	May 2011	Adler
D639861	June 2011	Langan et al.
D639862	June 2011	Langan et al.
D639863	June 2011	Langan et al.
D641421	July 2011	Langan et al.
D641422	July 2011	Langan et al.
D643468	August 2011	Langan et al.
D643469	August 2011	Langan et al.
D643470	August 2011	Langan et al.
D643471	August 2011	Langan et al.
D643472	August 2011	Langan et al.
D645094	September 2011	Langan et al.
D649196	November 2011	Langan et al.
D650440	December 2011	Irwin, Jr.
D683397	May 2013	Bratter
D707297	June 2014	Hoang et al.
D726254	April 2015	Kott
D765869	September 2016	Camper
2009/0143745	June 2009	Langan et al.
2011/0259775	October 2011	Bratter
2012/0089411	April 2012	Srnka et al.

Other References

US. Pharmacopeial Convention Chapter 17 Prescription Container Labeling, USP 36--NF 31 (Nov. 2012) (2 pages). cited by applicant.

Primary Examiner: Calabrese; Mary Ann
Attorney, Agent or Firm: Luedeka Neely Group, PC